Marshall Wace North America’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,956
| Closed | -$301K | – | 1701 |
|
|
2019
Q1 | $301K | Buy |
5,956
+2,182
| +58% | +$110K | ﹤0.01% | 901 |
|
|
2018
Q4 | $152K | Buy |
+3,774
| New | +$152K | ﹤0.01% | 1009 |
|
|
2018
Q3 | – | Sell |
-89,760
| Closed | -$6.79M | – | 1452 |
|
|
2018
Q2 | $6.79M | Buy |
89,760
+38,338
| +75% | +$2.9M | 0.04% | 436 |
|
|
2018
Q1 | $2.71M | Sell |
51,422
-29,915
| -37% | -$1.58M | 0.01% | 728 |
|
|
2017
Q4 | $4.35M | Buy |
+81,337
| New | +$4.35M | 0.02% | 616 |
|